These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 32969740)

  • 1. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
    Nikolova MP; Kumar EM; Chavali MS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.
    Alsehli M
    Saudi Pharm J; 2020 Mar; 28(3):255-265. PubMed ID: 32194326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of stimuli-responsive nanocarriers for drug and gene delivery.
    Ganta S; Devalapally H; Shahiwala A; Amiji M
    J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
    Chen X; Lei S; Lin J; Huang P
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics.
    Liu Y; Ou H; Pei X; Jiang B; Ma Y; Liu N; Wen C; Peng C; Hu X
    Curr Med Chem; 2021; 28(31):6307-6322. PubMed ID: 32503398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics.
    Hatakeyama H
    Chem Pharm Bull (Tokyo); 2017; 65(7):612-617. PubMed ID: 28674332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of stimuli-responsive nanoscale drug delivery systems in translational research.
    Gu M; Wang X; Toh TB; Chow EK
    Drug Discov Today; 2018 May; 23(5):1043-1052. PubMed ID: 29155366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers).
    Yadav KS; Upadhya A; Misra A
    Expert Opin Drug Deliv; 2021 Jan; 18(1):103-118. PubMed ID: 33017541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
    Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
    Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.
    Naser IH; Zaid M; Ali E; Jabar HI; Mustafa AN; Alubiady MHS; Ramadan MF; Muzammil K; Khalaf RM; Jalal SS; Alawadi AH; Alsalamy A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3747-3770. PubMed ID: 38095649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-sensitive drug delivery systems for site-specific antibiotic release.
    Nazir F; Tabish TA; Tariq F; Iftikhar S; Wasim R; Shahnaz G
    Drug Discov Today; 2022 Jun; 27(6):1698-1705. PubMed ID: 35219858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.